Literature DB >> 638020

Long-term effects of phenobarbitone-Na on male Fischer rats.

W H Butler.   

Abstract

Male inbred Fischer rats were fed phenobarbitone-Na at a level of 500 parts/10(6) in the diet for 1 week, followed by 1000 parts 10(6) for 103 weeks at which time the survivors were killed. Thirty-three treated rats survived to 80 weeks. Before 80 weeks, no animals showed hyperplastic lesions. Of the 33 rats surviving 80 weeks and more, 11 had foci of nodular hyperplasia. These foci were usually small, but one animal killed at 102 weeks had a lesion of 0.75 cm diameter, which compressed the surrounding liver. In one case was evidence of local invasion or metastasis found. All the livers had evidence of parenchymal cell damage. No evidence of nodular hyperplasia was found in the controls. It is concluded that there is no evidence to suggest that phenobarbitone-Na induced neoplasm in the liver of male Fischer rats.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638020      PMCID: PMC2009530          DOI: 10.1038/bjc.1978.62

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  5 in total

1.  Modification of diethylnitrosamine liver carcinogenesis with phenobarbital but not with immunosuppression.

Authors:  J H Weisburger; R M Madison; J M Ward; C Viguera; E K Weisburger
Journal:  J Natl Cancer Inst       Date:  1975-05       Impact factor: 13.506

2.  Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene.

Authors:  C Peraino; R J Fry; E Staffeldt
Journal:  Cancer Res       Date:  1971-10       Impact factor: 12.701

3.  Brief communication: Enhancement of spontaneous hepatic tumorigenesis in C3H mice by dietary phenobarbital.

Authors:  C Peraino; R J Fry; E Staffeldt
Journal:  J Natl Cancer Inst       Date:  1973-10       Impact factor: 13.506

4.  Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin, and dichlorodiphenyltrichloroethane on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat.

Authors:  C Peraino; R J Fry; E Staffeldt; J P Christopher
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

5.  Long-term administration of DDT or phenobarbital-Na in Wistar rats.

Authors:  L Rossi; M Ravera; G Repetti; L Santi
Journal:  Int J Cancer       Date:  1977-02-15       Impact factor: 7.396

  5 in total
  13 in total

1.  Dose-response analysis of epigenetic, metabolic, and apical endpoints after short-term exposure to experimental hepatotoxicants.

Authors:  Isabelle R Miousse; Lynea A Murphy; Haixia Lin; Melissa R Schisler; Jinchun Sun; Marie-Cecile G Chalbot; Radhakrishna Sura; Kamin Johnson; Matthew J LeBaron; Ilias G Kavouras; Laura K Schnackenberg; Richard D Beger; Reza J Rasoulpour; Igor Koturbash
Journal:  Food Chem Toxicol       Date:  2017-05-08       Impact factor: 6.023

2.  Characterization of polybrominated diphenyl ether toxicity in Wistar Han rats and use of liver microarray data for predicting disease susceptibilities.

Authors:  June K Dunnick; A Brix; H Cunny; M Vallant; K R Shockley
Journal:  Toxicol Pathol       Date:  2012       Impact factor: 1.902

Review 3.  Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators.

Authors:  Brian G Lake
Journal:  Toxicol Res (Camb)       Date:  2018-03-12       Impact factor: 3.524

4.  Effect of phenobarbital on the development of neoplastic lesions in the liver of cycasin-treated rats.

Authors:  E Uchida; I Hirono
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

5.  Dose-response relationship for phenobarbitone promotion of liver tumours initiated by single dose dimethylnitrosamine.

Authors:  H E Driver; A E McLean
Journal:  Br J Exp Pathol       Date:  1986-02

Review 6.  Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator.

Authors:  Clifford R Elcombe; Richard C Peffer; Douglas C Wolf; Jason Bailey; Remi Bars; David Bell; Russell C Cattley; Stephen S Ferguson; David Geter; Amber Goetz; Jay I Goodman; Susan Hester; Abigail Jacobs; Curtis J Omiecinski; Rita Schoeny; Wen Xie; Brian G Lake
Journal:  Crit Rev Toxicol       Date:  2013-11-04       Impact factor: 5.635

7.  Xenobiotic-induced hepatocyte proliferation associated with constitutive active/androstane receptor (CAR) or peroxisome proliferator-activated receptor α (PPARα) is enhanced by pregnane X receptor (PXR) activation in mice.

Authors:  Ryota Shizu; Satoshi Benoki; Yuki Numakura; Susumu Kodama; Masaaki Miyata; Yasushi Yamazoe; Kouichi Yoshinari
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

8.  An integrated functional genomic study of acute phenobarbital exposure in the rat.

Authors:  Claire L Waterman; Richard A Currie; Lisa A Cottrell; Jacky Dow; Jayne Wright; Catherine J Waterfield; Julian L Griffin
Journal:  BMC Genomics       Date:  2010-01-06       Impact factor: 3.969

9.  A metabolomics investigation of non-genotoxic carcinogenicity in the rat.

Authors:  Zsuzsanna Ament; Claire L Waterman; James A West; Catherine Waterfield; Richard A Currie; Jayne Wright; Julian L Griffin
Journal:  J Proteome Res       Date:  2013-11-07       Impact factor: 4.466

10.  Development of a Medium-term Animal Model Using gpt Delta Rats to Evaluate Chemical Carcinogenicity and Genotoxicity.

Authors:  Kohei Matsushita; Aki Kijima; Yuji Ishii; Shinji Takasu; Meilan Jin; Ken Kuroda; Hiroaki Kawaguchi; Noriaki Miyoshi; Takehiko Nohmi; Kumiko Ogawa; Takashi Umemura
Journal:  J Toxicol Pathol       Date:  2013-04-22       Impact factor: 1.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.